Direkt zum Inhalt
Merck

Reducing intestinal nematode infection: efficacy of albendazole and mebendazole.

Parasitology today (Personal ed.) (2000-02-01)
A Bennett, H Guyatt
ZUSAMMENFASSUNG

The widespread use of mebendazole and albendazole for treating intestinal nematode infections in human populations is raising concerns that careful monitoring pro- cedures should be in place to identify any emergence of drug resistance. In this article, Andy Bennett and Helen Guyatt discuss whether benchmark parasitological drug efficacy rates can be defined for these anthelmintics, by analysing published data on cure rates and egg reduction rates in the treatment of Ascaris lumbricoides, Trichuris trichiura and hookworm.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Mebendazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Mebendazol, analytical standard, ≥98% (HPLC)
Supelco
Mebendazol, VETRANAL®, analytical standard
Mebendazol, European Pharmacopoeia (EP) Reference Standard
Mebendazol für die Systemeignung, European Pharmacopoeia (EP) Reference Standard